Genflow Biosciences plc (LON:GENF)
London
· Delayed Price · Currency is GBP · Price in GBX 1.850
-0.025 (-1.33%)
At close: Mar 6, 2026
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 9.13 million as of March 6, 2026. Its market cap has increased by 37.42% in one year.
Market Cap
9.13M
Enterprise Value
8.85M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.85
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 9.13M, a decrease of -72.86%. That is a compound annual growth rate of -27.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 9.13M | - |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxford BioDynamics | 10.73M |
| Futura Medical | 7.19M |
| IXICO | 7.18M |
| OptiBiotix Health | 6.30M |
| Cizzle Biotechnology Holdings | 5.95M |
| CRISM Therapeutics | 5.82M |
| Fusion Antibodies | 17.50M |
| Nuformix | 4.43M |